Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 30 studies | 49% ± 20% | |
fibroblast | 21 studies | 43% ± 22% | |
astrocyte | 19 studies | 44% ± 19% | |
microglial cell | 16 studies | 62% ± 17% | |
macrophage | 15 studies | 47% ± 23% | |
oligodendrocyte | 15 studies | 45% ± 17% | |
pericyte | 14 studies | 45% ± 20% | |
smooth muscle cell | 13 studies | 45% ± 17% | |
oligodendrocyte precursor cell | 13 studies | 52% ± 19% | |
B cell | 12 studies | 33% ± 17% | |
glutamatergic neuron | 12 studies | 55% ± 25% | |
GABAergic neuron | 11 studies | 54% ± 22% | |
natural killer cell | 9 studies | 30% ± 14% | |
epithelial cell | 9 studies | 43% ± 21% | |
adipocyte | 9 studies | 57% ± 15% | |
mesothelial cell | 9 studies | 47% ± 16% | |
endothelial cell of lymphatic vessel | 9 studies | 52% ± 20% | |
dendritic cell | 8 studies | 41% ± 14% | |
mast cell | 8 studies | 44% ± 12% | |
basal cell | 8 studies | 46% ± 27% | |
ciliated cell | 7 studies | 35% ± 17% | |
myeloid cell | 7 studies | 45% ± 18% | |
T cell | 7 studies | 41% ± 15% | |
neuron | 6 studies | 54% ± 23% | |
interneuron | 6 studies | 65% ± 18% | |
endothelial cell of artery | 6 studies | 32% ± 17% | |
CD4-positive, alpha-beta T cell | 5 studies | 34% ± 12% | |
CD8-positive, alpha-beta T cell | 5 studies | 30% ± 12% | |
capillary endothelial cell | 5 studies | 35% ± 16% | |
cardiac muscle cell | 5 studies | 49% ± 11% | |
vein endothelial cell | 5 studies | 49% ± 20% | |
monocyte | 5 studies | 52% ± 9% | |
leukocyte | 5 studies | 57% ± 21% | |
club cell | 5 studies | 47% ± 20% | |
type I pneumocyte | 5 studies | 49% ± 10% | |
type II pneumocyte | 5 studies | 46% ± 10% | |
cholangiocyte | 4 studies | 54% ± 23% | |
glial cell | 4 studies | 37% ± 10% | |
granule cell | 4 studies | 53% ± 10% | |
plasma cell | 4 studies | 53% ± 15% | |
lymphocyte | 4 studies | 45% ± 20% | |
Mueller cell | 4 studies | 55% ± 14% | |
amacrine cell | 4 studies | 50% ± 9% | |
retina horizontal cell | 4 studies | 47% ± 12% | |
retinal cone cell | 4 studies | 42% ± 9% | |
retinal ganglion cell | 4 studies | 49% ± 18% | |
retinal rod cell | 4 studies | 59% ± 14% | |
goblet cell | 4 studies | 37% ± 31% | |
regulatory T cell | 4 studies | 36% ± 15% | |
endothelial cell of sinusoid | 3 studies | 27% ± 13% | |
hepatic stellate cell | 3 studies | 47% ± 22% | |
CD16-negative, CD56-bright natural killer cell, human | 3 studies | 33% ± 14% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 27% ± 13% | |
classical monocyte | 3 studies | 18% ± 1% | |
abnormal cell | 3 studies | 36% ± 26% | |
GABAergic interneuron | 3 studies | 48% ± 5% | |
progenitor cell | 3 studies | 53% ± 4% | |
effector memory CD8-positive, alpha-beta T cell | 3 studies | 36% ± 14% | |
endocardial cell | 3 studies | 41% ± 18% | |
mononuclear phagocyte | 3 studies | 39% ± 16% | |
GABAergic amacrine cell | 3 studies | 51% ± 14% | |
OFF-bipolar cell | 3 studies | 46% ± 23% | |
glycinergic amacrine cell | 3 studies | 53% ± 12% | |
endothelial cell of vascular tree | 3 studies | 60% ± 14% | |
hepatocyte | 3 studies | 66% ± 20% | |
retinal pigment epithelial cell | 3 studies | 55% ± 25% | |
connective tissue cell | 3 studies | 44% ± 22% | |
ependymal cell | 3 studies | 62% ± 12% | |
alveolar macrophage | 3 studies | 56% ± 12% | |
myofibroblast cell | 3 studies | 49% ± 20% | |
respiratory goblet cell | 3 studies | 52% ± 19% | |
muscle cell | 3 studies | 51% ± 22% | |
transit amplifying cell | 3 studies | 49% ± 33% | |
mural cell | 3 studies | 61% ± 8% | |
mucus secreting cell | 3 studies | 50% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1698.18 | 1444 / 1445 | 100% | 23.15 | 183 / 183 |
lung | 100% | 1749.51 | 577 / 578 | 98% | 13.82 | 1136 / 1155 |
stomach | 100% | 1276.97 | 359 / 359 | 98% | 13.84 | 280 / 286 |
intestine | 100% | 1923.93 | 966 / 966 | 98% | 12.31 | 514 / 527 |
breast | 100% | 2470.95 | 459 / 459 | 97% | 18.91 | 1080 / 1118 |
ovary | 100% | 2445.37 | 180 / 180 | 94% | 10.89 | 406 / 430 |
pancreas | 99% | 1027.03 | 326 / 328 | 94% | 10.39 | 168 / 178 |
uterus | 100% | 2784.84 | 170 / 170 | 93% | 17.55 | 429 / 459 |
bladder | 100% | 1974.48 | 21 / 21 | 93% | 11.35 | 469 / 504 |
thymus | 100% | 1855.87 | 653 / 653 | 91% | 12.38 | 551 / 605 |
skin | 100% | 2612.31 | 1809 / 1809 | 90% | 12.95 | 425 / 472 |
kidney | 100% | 1010.80 | 89 / 89 | 90% | 12.81 | 808 / 901 |
prostate | 100% | 1457.42 | 245 / 245 | 90% | 10.86 | 450 / 502 |
brain | 92% | 792.33 | 2431 / 2642 | 98% | 15.47 | 688 / 705 |
adrenal gland | 99% | 1296.19 | 256 / 258 | 68% | 4.68 | 157 / 230 |
liver | 89% | 545.40 | 201 / 226 | 69% | 5.35 | 281 / 406 |
adipose | 100% | 2547.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2358.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1849.62 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1229.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 22.54 | 43 / 45 |
heart | 92% | 962.44 | 788 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 1149.00 | 817 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 8.79 | 21 / 29 |
eye | 0% | 0 | 0 / 0 | 63% | 4.72 | 50 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090307 | Biological process | mitotic spindle assembly |
GO_0007062 | Biological process | sister chromatid cohesion |
GO_0051301 | Biological process | cell division |
GO_0034087 | Biological process | establishment of mitotic sister chromatid cohesion |
GO_0000775 | Cellular component | chromosome, centromeric region |
GO_0016363 | Cellular component | nuclear matrix |
GO_0097431 | Cellular component | mitotic spindle pole |
GO_0005694 | Cellular component | chromosome |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0008278 | Cellular component | cohesin complex |
GO_0000785 | Cellular component | chromatin |
GO_0030892 | Cellular component | mitotic cohesin complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | STAG1 |
Protein name | Cohesin subunit SA (SCC3 homolog) (Stromal antigen) Stromal antigen 1 Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1) |
Synonyms | SCC3 protein SA1 DKFZp781D1416 variant |
Description | FUNCTION: Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis. FUNCTION: Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. . |
Accessions | ENST00000383202.7 [Q8WVM7-1] ENST00000480733.1 Q68DW7 ENST00000434713.6 ENST00000236698.9 [Q8WVM7-2] H7C595 Q4LE48 Q8WVM7 C9JJQ0 F8WF82 ENST00000483235.5 ENST00000492318.1 F8WCB3 ENST00000487065.5 ENST00000629124.2 |